Literature DB >> 24064222

Protection from inflammatory bowel disease and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) involves suppression of oxidative stress and inflammatory cytokines.

Jun Fang1, Takahiro Seki, Tetsuya Tsukamoto, Haibo Qin, Hongzhuan Yin, Long Liao, Hideaki Nakamura, Hiroshi Maeda.   

Abstract

Oxidative stress is associated with various pathological processes including inflammatory bowel disease, which is a major cause of colon cancer. Here, we examined the antioxidative and anti-inflammatory effects of 4-vinyl-2,6-dimethoxyphenol (canolol), a potent antioxidant compound obtained from crude canola oil. Oral administration of 2% dextran sulfate sodium (DSS) resulted in the progression of colitis with shortening of the large bowel length. Administering a diet containing canolol significantly suppressed pathogenesis; diarrhea markedly improved and the length of large bowel returned to almost normal. Pathological examination clearly revealed improvement of colonic ulcers. Production of inflammatory cytokines, i.e. interleukin-12 and tumor necrosis factor-α, was significantly increased during this pathological process; their production was markedly inhibited by canolol. In the azoxymethane/DSS-induced colon cancer model, mice receiving canolol had a reduced occurrence of cancer, to 60%, compared with control mice, 100% of which had colon cancer. The numbers of tumors in each mouse were also significantly reduced in mice receiving the canolol-containing diet (5.6±2.0) compared with azoxymethane/DSS control mice (10.8±4.2). No apparent toxicity of canolol was observed. Moreover, inflammatory cytokines (i.e. cyclooxygenase-2, inducible nitric oxide synthase and tumor necrosis factor-α) and oxidative responding molecules, i.e. heme oxygenase-1, in colon were suppressed during this treatment. In a mouse colon 26 solid tumor model, canolol significantly suppressed cyclooxygenase-2 expression; however, no significant tumor growth inhibition was observed, suggesting that canolol preferably shows chemopreventive effects during the stages of initiation/promotion. Canolol may, thus, be considered a potential cancer preventive agent or supplement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24064222     DOI: 10.1093/carcin/bgt309

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

Review 1.  Recent advancement in understanding colitis-associated tumorigenesis.

Authors:  Daren Low; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

2.  Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice.

Authors:  Chi H L Dinh; Yinghua Yu; Alexander Szabo; Qingsheng Zhang; Peng Zhang; Xu-Feng Huang
Journal:  J Histochem Cytochem       Date:  2016-02-26       Impact factor: 2.479

3.  Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic mice.

Authors:  Donghui Cao; Jing Jiang; Tetsuya Tsukamoto; Ruming Liu; Lin Ma; Zhifang Jia; Fei Kong; Masanobu Oshima; Xueyuan Cao
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

4.  A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis.

Authors:  Wei Yu; Zhihong Li; Fei Long; Wen Chen; Yurong Geng; Zhiyong Xie; Meicun Yao; Bo Han; Teigang Liu
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

5.  Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice.

Authors:  Jiangtao Zhou; Lihua Tan; Jianhui Xie; Zhengquan Lai; Yanfeng Huang; Chang Qu; Dandan Luo; Zhixiu Lin; Ping Huang; Ziren Su; Youliang Xie
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 6.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

Review 7.  Sinapic Acid and Its Derivatives as Medicine in Oxidative Stress-Induced Diseases and Aging.

Authors:  Chunye Chen
Journal:  Oxid Med Cell Longev       Date:  2015-11-10       Impact factor: 6.543

8.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01

9.  Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon.

Authors:  Yohei Shirakami; Takahiro Kochi; Masaya Kubota; Hiroyasu Sakai; Takashi Ibuka; Kazuto Yoshimi; Takashi Kuramoto; Takuji Tanaka; Masahito Shimizu; Mitsuru Seishima
Journal:  Oncotarget       Date:  2018-09-21

10.  The Antioxidant and Anti-Inflammatory Properties of Anacardium occidentale L. Cashew Nuts in a Mouse Model of Colitis.

Authors:  Rosalba Siracusa; Roberta Fusco; Alesso Filippo Peritore; Marika Cordaro; Ramona D'Amico; Tiziana Genovese; Enrico Gugliandolo; Rosalia Crupi; Antonella Smeriglio; Giuseppina Mandalari; Salvatore Cuzzocrea; Rosanna Di Paola; Daniela Impellizzeri
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.